# Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

> **NCT01379703** · — · COMPLETED · sponsor: **Abbott** · enrollment: 2288 (actual)

## Conditions studied

- HIV-1 Patients

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01379703
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 2288 (ACTUAL)
- **Last updated:** 2011-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379703, "Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01379703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*